Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.

Founded

2007

Raised

$164M

Follow us

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Add round

05 Nov 2014

$45,000,000

Post-IPO equity

09 May 2013

$60,000,000

Venture capital (Series C)

Forest Laboratories

14 Jul 2010

$35,000,000

Venture capital (Series B)

Polaris Partners, Alta Partners, NEA, +1

01 Mar 2008

$24,000,000

Venture capital (Series A)

Polaris Partners, Alta Partners, NEA, +1